BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32505675)

  • 21. Generation of Properly Folded Epidermal Growth Factor-Like (EGF) Repeats and Glycosyltransferases Enables In Vitro O-Glycosylation.
    Ma C; Tsukamoto Y; Takeuchi H
    Methods Mol Biol; 2022; 2472():27-38. PubMed ID: 35674889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two novel protein
    Takeuchi H; Schneider M; Williamson DB; Ito A; Takeuchi M; Handford PA; Haltiwanger RS
    Proc Natl Acad Sci U S A; 2018 Sep; 115(36):E8395-E8402. PubMed ID: 30127001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism and transportation pathways of GDP-fucose that are required for the O-fucosylation of Notch.
    Yamakawa T; Ayukawa T; Matsuno K
    Adv Exp Med Biol; 2012; 727():37-46. PubMed ID: 22399337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Canonical Notch ligands and Fringes have distinct effects on NOTCH1 and NOTCH2.
    Kakuda S; LoPilato RK; Ito A; Haltiwanger RS
    J Biol Chem; 2020 Oct; 295(43):14710-14722. PubMed ID: 32820046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping Sites of O-Glycosylation and Fringe Elongation on Drosophila Notch.
    Harvey BM; Rana NA; Moss H; Leonardi J; Jafar-Nejad H; Haltiwanger RS
    J Biol Chem; 2016 Jul; 291(31):16348-60. PubMed ID: 27268051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of Notch signaling during T- and B-cell development by O-fucose glycans.
    Stanley P; Guidos CJ
    Immunol Rev; 2009 Jul; 230(1):201-15. PubMed ID: 19594638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic Human NOTCH1 EGF Modules Unraveled Molecular Mechanisms for the Structural and Functional Roles of Calcium Ions and O-Glycans in the Ligand-Binding Region.
    Hayakawa S; Koide R; Hinou H; Nishimura S
    Biochemistry; 2016 Feb; 55(5):776-87. PubMed ID: 26765751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xylosyl Extension of
    Urata Y; Saiki W; Tsukamoto Y; Sago H; Hibi H; Okajima T; Takeuchi H
    Cells; 2020 May; 9(5):. PubMed ID: 32423029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A modifier in the 129S2/SvPasCrl genome is responsible for the viability of Notch1[12f/12f] mice.
    Varshney S; Wei HX; Batista F; Nauman M; Sundaram S; Siminovitch K; Tanwar A; Stanley P
    BMC Dev Biol; 2019 Oct; 19(1):19. PubMed ID: 31590629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammalian Notch1 is modified with two unusual forms of O-linked glycosylation found on epidermal growth factor-like modules.
    Moloney DJ; Shair LH; Lu FM; Xia J; Locke R; Matta KL; Haltiwanger RS
    J Biol Chem; 2000 Mar; 275(13):9604-11. PubMed ID: 10734111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual Roles of O-Glucose Glycans Redundant with Monosaccharide O-Fucose on Notch in Notch Trafficking.
    Matsumoto K; Ayukawa T; Ishio A; Sasamura T; Yamakawa T; Matsuno K
    J Biol Chem; 2016 Jun; 291(26):13743-52. PubMed ID: 27129198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibodies against the extracellular domain of human Notch1 receptor reveal the critical role of epidermal-growth-factor-like repeats 25-26 in ligand binding and receptor activation.
    Sharma A; Rangarajan A; Dighe RR
    Biochem J; 2013 Jan; 449(2):519-30. PubMed ID: 23072667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two NOTCH1 O-fucose sites have opposing functions in mouse retinal angiogenesis.
    LoPilato RK; Kroeger H; Mohan SK; Lauderdale JD; Grimsey N; Haltiwanger RS
    Glycobiology; 2023 Oct; 33(8):661-672. PubMed ID: 37329502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The threonine that carries fucose, but not fucose, is required for Cripto to facilitate Nodal signaling.
    Shi S; Ge C; Luo Y; Hou X; Haltiwanger RS; Stanley P
    J Biol Chem; 2007 Jul; 282(28):20133-41. PubMed ID: 17504756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modification of epidermal growth factor-like repeats with O-fucose. Molecular cloning and expression of a novel GDP-fucose protein O-fucosyltransferase.
    Wang Y; Shao L; Shi S; Harris RJ; Spellman MW; Stanley P; Haltiwanger RS
    J Biol Chem; 2001 Oct; 276(43):40338-45. PubMed ID: 11524432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diseases related to Notch glycosylation.
    Matsumoto K; Luther KB; Haltiwanger RS
    Mol Aspects Med; 2021 Jun; 79():100938. PubMed ID: 33341260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital diseases caused by defective
    Tashima Y; Okajima T
    Nagoya J Med Sci; 2018 Aug; 80(3):299-307. PubMed ID: 30214079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. O-fucosylation of the notch ligand mDLL1 by POFUT1 is dispensable for ligand function.
    Müller J; Rana NA; Serth K; Kakuda S; Haltiwanger RS; Gossler A
    PLoS One; 2014; 9(2):e88571. PubMed ID: 24533113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Delta-induced Notch signaling using fucose analogs.
    Schneider M; Kumar V; Nordstrøm LU; Feng L; Takeuchi H; Hao H; Luca VC; Garcia KC; Stanley P; Wu P; Haltiwanger RS
    Nat Chem Biol; 2018 Jan; 14(1):65-71. PubMed ID: 29176671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structural biology. Structural basis for Notch1 engagement of Delta-like 4.
    Luca VC; Jude KM; Pierce NW; Nachury MV; Fischer S; Garcia KC
    Science; 2015 Feb; 347(6224):847-53. PubMed ID: 25700513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.